McGill University Health Centre/Glen Site/Cedars Cancer Centre

Montreal, Quebec H4A 3J1

0 studies enrolling now · 3 studies all time

What they study most

Head and Neck Cancer, Leukemia, Metastatic Merkel Cell Carcinoma

Studies at this site

• Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck — Running, not enrolling
• A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia — Completed
• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) — Completed